Denial Watch, from public records
Health coverage in America, by the numbers
Why it pays to appeal a denial, who denies the most, what gets denied and why, and who has no coverage at all, from government and insurer records. On HealthCare.gov plans, insurers denied about one in six in-network claims in 2025, 83.5 million among reporting insurers, and very few are appealed.
0
HealthCare.gov claims denied today, at 2025's pace
An illustration, not a live count: at 2025's pace on HealthCare.gov, this many in-network claims would have been denied since midnight. Employer plans, Medicaid, Medicare and state-run marketplaces aren't included.
0denied per day in 2025, on average
Open enrollment for 2027
Compare plans and costs for 2027, even if you'll be renewed automatically.
23.1 million picked a marketplace plan
for 2026 in open enrollment, including people renewed automaticallyColours in the charts: blue, denials; green, good for patients, such as appeals won; purple, coverage and health, such as the uninsured; pink, drug spending; red, only where something got worse; grey, no data.
Why should I appeal?
Very few denials are appealed, and more than a quarter of appeals win.
How we got these numbers: Why should I appeal?
Independent review in California
On HealthCare.gov plans, the federal marketplace, insurers reversed 27% of the internal claim appeals they reported in 2025 (64,014 of 234,979). Independent review is the step after an insurer's own appeal, when outside doctors who don't work for the insurer decide. We show California because its Department of Managed Health Care publishes every independent review decision it oversees, case by case. There, in 2025, outside doctors overturned 72% of the denials they reviewed, up from 47% in 2017. These are cases people chose to take that far, and that qualified, so the rate isn't the chance that any denial would be reversed.
Denials overturned, decided in the patient's favour
Denials overturned at independent review, California
Overturned by type of care, 2021 to 2025
See how others' appeals went
- California's independent review decisions: every case from the state's Department of Managed Health Care since 2001, with the kind of care and the outcome, as a spreadsheet file.
- New York's external appeal decisions: case by case, with the plan and whether the denial was upheld or overturned.
- For your own appeal, ProPublica's Claim File Helper helps you write a letter asking your insurer for your claim file, the records it used to decide on your claim.
Ready to try? Fight Health Insurance drafts an appeal from your denial letter for free. What you can do has the steps and deadlines.
Who is denying the most?
It depends on where you live and which company covers you.
How we got these numbers: Who is denying the most?
Denial rates by state
Rates run from about 6% to 26% across 29 HealthCare.gov states. Share of in-network claims denied by HealthCare.gov insurers in each state, 2025. Grey states run their own marketplace, so they aren't in this data. Pick a state to see its insurers. A grey state shows what it publishes instead, and six of them also have insurers in the table below, from other sources or years.
Every state's figure, as a table
Every state's denial rate
Share of in-network claims denied, by state: the 29 HealthCare.gov states from the map, highest first. Below them, on the same scale but listed apart, are six grey states we found a figure for elsewhere: California (2025 claims) and Pennsylvania (2024 claims) from their insurers' own reports on the same federal form, and Georgia, Illinois, Oregon and Virginia from the last year CMS's files include them.
- HealthCare.gov insurers, 2025 claims (FHI's calculation from CMS's data)
Each bar is the % of in-network claims insurers denied in that state.
Six grey states, from other sources or years
These sources and years aren't strictly comparable: California's and Pennsylvania's reports can count plans sold outside their marketplaces, which CMS's figures leave out. California's 2025 figure is missing Health Net and Aetna, whose 2025 reports we couldn't read or find. Pennsylvania, Georgia, Illinois, Oregon and Virginia are from earlier years. So don't rank those six against the 2025 states.
- California (2025 claims) and Pennsylvania (2024 claims) insurers' own reports on the same federal form (FHI's calculation from Covered California's and the Pennsylvania Insurance Department's data)
- HealthCare.gov insurers in the last year CMS's files include the state, given on the bar (FHI's calculation from CMS's data)
Show these figures as a table
| State | Denied | FHI's calculation from |
|---|---|---|
| Hawaii | 26.3% | CMS, 2025 claims |
| Alaska | 24.8% | CMS, 2025 claims |
| Delaware | 20.3% | CMS, 2025 claims |
| Wyoming | 20.2% | CMS, 2025 claims |
| West Virginia | 20.1% | CMS, 2025 claims |
| North Carolina | 19.7% | CMS, 2025 claims |
| Louisiana | 18.7% | CMS, 2025 claims |
| Iowa | 17.7% | CMS, 2025 claims |
| Michigan | 17.7% | CMS, 2025 claims |
| Tennessee | 17.5% | CMS, 2025 claims |
| Texas | 17.3% | CMS, 2025 claims |
| Utah | 17.3% | CMS, 2025 claims |
| Oklahoma | 17.0% | CMS, 2025 claims |
| Nebraska | 16.6% | CMS, 2025 claims |
| Alabama | 16.3% | CMS, 2025 claims |
| Arizona | 16.1% | CMS, 2025 claims |
| South Carolina | 15.7% | CMS, 2025 claims |
| Wisconsin | 15.4% | CMS, 2025 claims |
| Arkansas | 13.5% | CMS, 2025 claims |
| Florida | 13.2% | CMS, 2025 claims |
| Montana | 12.7% | CMS, 2025 claims |
| Kansas | 12.7% | CMS, 2025 claims |
| Ohio | 12.7% | CMS, 2025 claims |
| Missouri | 11.7% | CMS, 2025 claims |
| Mississippi | 11.2% | CMS, 2025 claims |
| Indiana | 10.6% | CMS, 2025 claims |
| New Hampshire | 8.0% | CMS, 2025 claims |
| North Dakota | 6.8% | CMS, 2025 claims |
| South Dakota | 5.9% | CMS, 2025 claims |
| Six grey states, from other sources or years | ||
| California | 15.7% | Covered California, 2025 claims |
| Pennsylvania | 14.2% | Pennsylvania Insurance Department, 2024 claims |
| Georgia | 15.8% | CMS, 2022 claims |
| Illinois | 19.6% | CMS, 2023 claims |
| Oregon | 10.9% | CMS, 2024 claims |
| Virginia | 16.4% | CMS, 2021 claims |
Denial rates by insurer
In some states, one insurer denies four or more times as often as another. In-network denial rates for each insurer with at least 50,000 in-network claims, as each company reported them. The 29 HealthCare.gov states show 2025 claims. Six states with their own marketplace show figures from other sources or years: California (2025) and Pennsylvania (2024) from insurers' own reports, and Georgia, Illinois, Oregon and Virginia from the last year CMS's files include them. They aren't a quality rating: they depend on the kinds of care each plan's members use.
Picking a 2027 marketplace plan? Choose your state below to see its insurers' rates (2025 claims in most states), then compare plans on HealthCare.gov or your state's marketplace. Some of these insurers don't sell plans for 2027, so check which ones do. Oregon residents compare 2027 plans at ExploreHealthOR.gov instead.
Prior authorization denials
Insurers now post how often they deny prior authorization, and the spread is wide. Prior authorization is when a plan has to approve care before you get it. Since March 2026, Medicare Advantage plans, Medicaid plans, state Medicaid programs and most HealthCare.gov insurers have had to post what share of 2025 requests for medical care and equipment they denied. Prescription drugs aren't included. Insurers count differently, so compare within one kind of plan.
Not every plan. Big insurers post one report per contract or state, and these 89 are the largest we found. AuthDenied has a much fuller collection, more than 1,100 plans, and KFF compares the largest insurers.
Medicare Advantage plans: share of standard requests denied
Share of standard requests denied
All four kinds of plan share one scale, up to the highest rate in any of them, so the same rate gets the same length of bar whichever button you pick.
Your plan's clock
Starting in 2026, Medicare Advantage, Medicaid and Children's Health Insurance Program (CHIP) plans must answer a prior authorization request by these deadlines. A state-run CHIP program may follow its state's law instead.
- Urgent requests: 72 hours.
- Other requests: 7 days.
- More time: sometimes up to 14 more days, for either kind.
- A missed deadline: in Medicare Advantage and Medicaid plans, it counts as a denial you can appeal.
A denial must tell your doctor the specific reason. HealthCare.gov insurers must give the reason too, but they still have 15 days (72 hours if urgent). These rules don't cover prescription drugs, job-based plans, state-run marketplaces (even those that sign people up through HealthCare.gov) or Original Medicare.
From CMS's fact sheet on the rule and the federal regulations for each kind of plan, checked October 23, 2026.
What are they denying, and why?
Care outside a plan's network is denied about twice as often, and "not medically necessary" is rarely the reason given.
Most reasons insurers report are paperwork, plan rules or "other".
How we got these numbers: What are they denying, and why?
Denials over time
A lower denial rate in 2025, though we'd read it with care. HealthCare.gov plans, by the year the claims were made. Insurers denied 15.6% of in-network claims in 2025, down from 18.7% in 2024. Denials held at about 83.5 million while claims rose 18%, as enrollment grew. That may be a good sign, but this data can't prove it: most of the drop comes from about ten insurers whose reported rates fell sharply in one year, insurers report these numbers themselves, and we can't tell a real change from a change in how they count. More on the 2025 drop. Insurers have reported out-of-network claims only since 2022, and denied 31% of them in 2025, about twice the in-network rate.
Share of claims denied
Reasons given for denials
"Not medically necessary" is a small share of the reasons given. Reasons insurers reported for denied in-network claims in 2025, as a share of all reasons reported. A claim can be counted under more than one reason, so these are shares of reasons, not of claims. "Other" is the largest group, which means many denials aren't explained in this data. "Not medically necessary" is 6.5% of all reasons (5.7 million of 86.6 million).
Share of all reasons given for denials Darker, in bold: the reasons about medical judgment
Who doesn't have coverage?
About 27 million people under 65 in 2024, about 1 in 10, from 3.3% in Massachusetts to 19.1% in Texas.
Uninsured rates for people under 65 are Census estimates for 2024, and the health measures are CDC estimates for adults, mostly from 2023. States with higher uninsured rates also tend to have more adults in fair or poor health. The link is weaker for diabetes and absent for depression. This compares states, not people, and doesn't show that one causes the other.
How we got these numbers: Who doesn't have coverage?
Every state's figure, as a table
Where people get coverage
Nearly half of people have coverage only through a job. About 4 in 100 have a marketplace plan.
All ages, each person counted once, as of Census's interviews from February to April 2026.
- Job-based plan only 47.5%
- Marketplace plan only 3.9%
- Plan bought outside the marketplace only 2.3%
- Medicare, alone or with another kind 20.2%
- Medicaid or CHIP only 13.3%
- Military (TRICARE) only or VA only 2.1%
- More than one kind, no Medicare 2.1%
- Uninsured 8.6%
See marketplace coverage year by year on the open enrollment page.
What care costs
Where the money goes: prescription drugs in Medicare
How we got these numbers: Drug costs
A Medicare price tag marks a drug whose price Medicare negotiated with the drugmaker, or picked for a price that starts in 2028. That price caps what Medicare drug plans pay for the drug, plus a pharmacy fee, and it's not your copay: your plan sets your share, based on that price, so ask your plan how it affects you. Xarelto's ends after 2026 because a generic is now sold. Medicare's list of negotiated drugs.
Medicare Part D spending, before rebates
Help with Medicare drug costs
- A yearly cap. In a Medicare drug plan, or a Medicare Advantage plan with drug coverage, the most you pay for covered drugs is $2,100 in 2026 and $2,400 in 2027. After that you pay nothing for covered drugs for the rest of the year. Discount cards used instead of your plan don't count toward it. How drug costs work.
- Extra Help. If your income and savings are limited, Medicare's Extra Help helps pay drug plan premiums, deductibles and copays. In 2027 its copays are at most $5.80 for a generic and $14.40 for a brand-name drug. See if you qualify for Extra Help.
- Monthly payments. The Medicare Prescription Payment Plan spreads what you owe for drugs across the year. It's free, but it doesn't lower your costs, and Medicare says it may not be the best choice if you join after September, so think about it for 2027. To join, contact your plan. How the payment plan works.
- Free advice. Your State Health Insurance Assistance Program (SHIP) gives free one-on-one Medicare counseling, including on drug plans. Find yours at shiphelp.org or by calling 1-877-839-2675.
Checked October 23, 2026.
What you can do
A denial is a first answer, not a final one
1. Find out why
Ask your insurer for the specific reason and the documents they used. Employer, marketplace and Medicaid plans have to give you the claim file for free. Medicare Advantage and Medicare drug plans have to give it to you too, but can charge for copying and mailing it. If the reason is paperwork or coding, a corrected claim may fix it without an appeal.
2. Appeal inside the plan
Employer and marketplace plans give you at least 180 days. Medicare Advantage gives 65 days from the date on the notice, and Medicaid plans give 60. Your denial letter has your deadline. In 2025, HealthCare.gov insurers reversed more than a quarter of the internal claim appeals people filed, and there was about 1 appeal for every 350 in-network denials.
3. Ask for independent review
If the plan says no again, most denials about medical judgment can go to outside doctors, through your state or the federal process. In California, independent reviewers sided with patients in 72% of the cases they decided in 2025.
4. Get help writing it
Fight Health Insurance drafts an appeal from your denial letter for free, with the medical evidence and the rules that apply to your plan. Not sure what your denial means? Get it explained.
Who to call
Start your appeal with the steps in your denial letter. For questions or complaints, these offices can help, by kind of coverage.
- A job-based plan from a private employer (not a government or church plan): the U.S. Labor Department's benefits advisors, at askebsa.dol.gov or 1-866-444-3272.
- Medicare, including Medicare Advantage and drug plans: 1-800-MEDICARE (1-800-633-4227, TTY 1-877-486-2048), or Medicare's complaint form for problems with a plan. To fight a denial, appeal with the steps in your notice.
- A plan you bought yourself, or a job-based plan your employer buys from an insurer: your state's insurance department. Find it in this directory of state insurance departments.
- A marketplace decision about whether you can buy a plan or get savings (or how much, or a special enrollment period): appeal to the marketplace itself, generally within 90 days of your eligibility notice, on HealthCare.gov's appeals page or your state marketplace's site. A denial from your insurer is a different appeal, the kind the rest of this page and Fight Health Insurance help with.
- A surprise medical bill: the No Surprises Help Desk, 1-800-985-3059, or CMS's medical bill rights page.
- Free Medicare counseling: your State Health Insurance Assistance Program (SHIP). Find yours at shiphelp.org or by calling 1-877-839-2675.
- Your state: our state help pages list each state's insurance department, Medicaid office, SHIP and independent review.
Numbers and links checked October 22, 2026.
What this can't show yet
The biggest plans report the least
Most Americans get coverage through an employer. The Affordable Care Act calls for those plans to report denials too, but federal regulators have never put that into effect. A few states, like Connecticut, publish figures for the plans they regulate, which leaves out employers' self-funded plans. That gap is part of the story.
Employer plans
About half the country. Federal law calls for denial reporting, but regulators have never put it into effect.
Medicaid and Medicare Advantage
No claim-denial data by state. The prior-authorization reports above cover requests made before care, a different step from claims.
Daily numbers
No public source reports denials more often than once a year. The counter above spreads a yearly total evenly; it isn't a live feed.
Procedure prices
Hospital price files are public but messy, and the standard procedure names are licensed. A future cost explorer would use plain-language names.
Beyond this page
Where to find more data like this
AuthDenied
Prior authorization denial rates, appeal results and decision times for more than 1,100 Medicare Advantage, Medicaid and HealthCare.gov plans, from their 2025 reports. No ads.
PlainInsurer
Claim denial rates for each HealthCare.gov insurer by state, with appeals filed and won, from the same federal files we use. It also counts care from doctors and hospitals outside the plan's network, which is denied more often, so some of its rates run higher than our in-network ones. Paid for by ads.
KFF
A nonprofit health policy research, polling, and news organization. Its reports cover HealthCare.gov claim denials and appeals (2024 claims, with a spreadsheet by insurer and state) and the largest insurers' 2025 prior authorization reports.
Know a public data source we should include? Send it our way. If you run one of these, or can connect us with the people who do, we'd like to join forces on making health care data easier to understand. Get in touch.
Checked October 23, 2026.
Where the numbers come from
Sources and method
How we got the numbers in each section, and the choices we made.
The denial and appeal records
- Denials and appeals: CMS Transparency in Coverage public use files, plan years 2022 to 2027, which report claims from 2020 to 2025. Individual-market medical plans only, in states using HealthCare.gov. Insurers report these figures to CMS themselves. Numbers are FHI's totals of issuer-level figures, not CMS's own. For 2024 they closely match KFF's analysis (KFF leaves out insurers with 1,000 or fewer claims, so it counts 39 fewer appeals); the 2025 figures don't have that outside check yet. The headline figures count in-network claims, as KFF does: 83.5 million denials in 2025, 16% of in-network claims, and 241,596 internal claim appeals, about 1 for every 350 of those denials. The map and the trend chart open on in-network claims too. The trend chart can switch to out-of-network claims or all claims, and the map to all claims; the insurer table counts in-network claims only. Cells CMS suppresses for small counts are left out.
Open enrollment and marketplace coverage: the plan picks at the top of this page are CMS's count, from its 2026 Marketplace Open Enrollment Period public use files. The marketplace numbers, and how we got them, are in the open enrollment page's sources.
Why should I appeal?
- Source: the denial and appeal records above.
- Appeals: the counts aren't split by network, so the 1-in-350 figure compares two totals, as KFF's does. Appeal win rates count only insurers that reported both appeals filed and appeals won, and an appeal won in part counts as won. Three insurers' 2025 appeals-won counts look like reporting errors, so we leave them out too: CMS marked their win rates as suppressed but printed the counts anyway. Their appeals still count as filed. With them, the 2025 rate would be 26.8%. We show only the latest year's win rate, because the insurers reporting change from year to year, and because the 2027 file counts appeals of claims and appeals of requests made before care separately, which earlier files didn't. We use its appeals of claims.
- Independent medical review: California DMHC IMR determinations, via the CalHHS Open Data Portal, 2010 to 2025 (file as published June 2026), with exact duplicate records removed. That's the step after an insurer's own appeal. Its rate isn't directly comparable with the insurers' own appeal results: different plans, people and review processes.
Who is denying the most?
- Source: the denial and appeal records above.
- State map: Grey states run their own marketplace, so their insurers don't report to HealthCare.gov and aren't shown. That now includes Georgia, Illinois and Oregon, which have since moved to their own, so their latest claims aren't here either. Picking a grey state links to the best public source that state has, such as independent review results, appeal reports or complaint records, checked October 25, 2026 (Oregon's on November 1, 2026); Rhode Island and Kentucky publish nothing current, so theirs says so with no link. Those figures come from each state, often cover employer plans or other measures, and aren't comparable with CMS's rates. Picking Georgia, Illinois, Oregon or Virginia also shows its in-network denial rate from the latest CMS file that includes its insurers (2022 claims for Georgia, 2023 for Illinois, 2024 for Oregon, 2021 for Virginia), FHI's calculation from CMS's data on the same measure as the map. Those are older years, so don't rank them against the 2025 states. A state that a view leaves out has an outlined tile, and the line under the map says why. In Hawaii and West Virginia one insurer reports, and in Alaska, Delaware, Mississippi, Montana and Wyoming two do, so those states' figures are those companies' figures. The small type on each tile, shown when the map is wide enough, is the lowest to the highest rate among that state's insurers in the insurer table. The map opens on in-network claims, and we don't map out-of-network claims by state (see What are they denying? below).
- Every state chart: it puts the map's 2025 rates beside two other kinds of in-network denial rates, both FHI's calculations: from the 2025 claims that 9 insurers in California (the ones with usable reports) and the 2024 claims that 11 in Pennsylvania reported on the same federal form, posted by Covered California and the Pennsylvania Insurance Department, and from the last CMS files that include Georgia, Illinois, Oregon and Virginia, described above. California's rate is 15.7% for 2025 and was 16.8% for 2024, but that isn't a clean comparison: Health Net (22.5% of 4.2 million claims in 2024) has no readable 2025 report, because its link opens another insurer's file, and Inland Empire Health Plan and CCHP Health Plan had no usable 2024 figure. Pennsylvania's 2025 claims weren't posted when we checked.
- Insurer table: Each insurer that handled at least 50,000 in-network claims. For the 29 HealthCare.gov states, that's each reporting insurer in 2025, from CMS's files. For California and Pennsylvania, it's each insurer in the reports described in the every-state chart note above; the three California insurers we leave out are named under the table, with why. Covered California posts each insurer's plan rows, not its totals, so California's figures add up those rows, and it posts no appeal counts. California's and Pennsylvania's reports can count plans sold outside the marketplace, which CMS's figures leave out, and Kaiser Permanente's and Valley Health Plan's rates moved more than 10 points from their reports for 2024 claims, so compare insurers within a state and read one year with care. Capital Health Plan in Florida isn't listed: it reported denying 448,953 of 466,619 in-network claims in 2025 (96%), after 6.5% the year before, which looks like a reporting error, so its in-network counts are left out of every figure on this page. For Georgia, Illinois, Oregon and Virginia, it's each insurer in the last CMS file that includes the state (2022, 2023, 2024 and 2021 claims), by the same rules; some of them may not sell there now. These are unadjusted rates, not a quality rating: they depend on the kinds of care each plan's members use and how each company counts claims. Appeal win rates are shown only for insurers with at least 30 appeals, and "not reported" means CMS withheld the number won or we left it out as a likely reporting error (see Why should I appeal? above). Why there are no out-of-network or all-claims rates: see What are they denying? below.
- Picking a 2027 plan: Oregon's move to its own marketplace is from HealthCare.gov's state page, and insurers leaving the marketplace for 2027 from KFF's tracker, checked October 19, 2026.
- Prior authorization: each insurer's or state's own 2025 report, posted under the CMS prior authorization rule, copied as posted with a link to the source for every row. Reports whose scope or units weren't clear are left out. We gathered them from insurers' and states' own websites.
- Prior authorization deadlines: the rule as published in the Federal Register (CMS-0057-F, February 2024) and the regulations for each kind of plan: 42 CFR 422.122, 422.568 and 422.572 (Medicare Advantage), 440.230 and 431.80 (state Medicaid), 438.210 and 438.404 (Medicaid plans), 457.495 and 457.1230 (CHIP), and 45 CFR 156.223 and 147.136 (HealthCare.gov insurers). Insurers in states that run their own marketplace through HealthCare.gov aren't covered. Medicaid plans' deadlines start with their first contract year beginning on or after January 1, 2026. A state-run CHIP program may follow its state's existing prior authorization law instead. CMS proposed adding prescription drugs in April 2026; we found no final rule. Checked October 23, 2026.
What are they denying, and why?
- Source: the denial and appeal records above.
- In network and out: CMS's data dictionary defines the one claims count in the files for 2020 and 2021 as in-network only, so the other two views start in 2022. In 2025 insurers denied 16.7 million of 53.0 million out-of-network claims (31%) and 98.8 million of 582.4 million claims overall (17%). For 9.4 million of those out-of-network denials, more than half, insurers gave the reason that the plan doesn't cover care outside its network (CMS's closed-network reason, reported per plan; one claim can count under more than one reason). KFF doesn't break out-of-network rates down by state or insurer, and we don't map them by state: in 2025, 99 of the 135 insurers reporting them sold only HMO or EPO plans (from CMS's 2025 plan list), which mostly don't cover out-of-network care by design, so a state's rate would mostly show which kinds of plans its insurers sell, not how they handle claims. We don't show them insurer by insurer either: even among insurers that also sold PPO or POS plans, many had most of their out-of-network claims on HMO or EPO plans, or gave that closed-network reason for most of those denials. The insurer table has no all-claims rates for the same reason: they fold in those out-of-network denials, so an insurer whose plans mostly don't cover out-of-network care could rank worse for that alone. One insurer reported more out-of-network denials than claims in 2025, which can't be right: Blue Care Network of Michigan. We leave it out of the out-of-network and all-claims figures, and the map's all-claims view shows no figure for Michigan. Blue Cross and Blue Shield of Kansas (2022 claims), Blue Cross Blue Shield of North Dakota (2023 and 2024) and Moda Health Plan in Alaska (2024) are left out of those years the same way. There's no out-of-network change from 2024, which mostly reflects which insurers reported, and no out-of-network appeals figure. The states and insurers that report change each year (Georgia, Illinois and Oregon have since left HealthCare.gov, and insurers that leave stop reporting), and rates aren't adjusted for the kinds of care people used.
- The 2025 drop: the in-network rate fell from 18.7% to 15.6%, but we can't say how much of that is fewer denials. The 2025 file covers only insurers selling plans for 2027, so 40 insurers in the 2024 file aren't in it, and Oregon isn't either. Among the 119 insurers with figures in both years, the rate fell from 18.8% to 16.4%; 76 went down and 43 went up. Most of that fall comes from about ten insurers: without the ten that moved the total most, the rest went from 17.7% to 17.8%. Those ten include several Celtic and other Centene plans, Health Options and Florida Blue, whose reported claims often grew fast at the same time, which could be real or a change in how they count. CMS also reorganized the file for 2025 claims, adding counts of requests made before care and splitting more figures by network; its in-network claims columns keep the same names, so we kept them in the same trend. Insurers report these numbers themselves. We'll check them against outside analyses when those come out.
- Denial reasons: reported per plan for in-network claims, and one claim can count under several reasons, so they're shown as shares of reasons; like KFF, we leave out CMS's closed-network reason, covered above.
Who doesn't have coverage?
- Uninsured: Census Small Area Health Insurance Estimates, under 65, 2023 and 2024. The national figure adds up the state estimates.
- Uninsured and health: compared across 48 states and DC (Kentucky and Pennsylvania have no 2023 estimates). The uninsured rate goes with the share of adults in fair or poor health (correlation 0.52), less with diabetes (0.36), and not with depression (-0.10).
- Health measures: CDC PLACES county data, 2025 release (mostly 2023 BRFSS). Adult crude prevalence, county estimates weighted by adult population. Kentucky and Pennsylvania have no 2023 estimates in this release. Use of CDC data does not imply CDC endorsement.
- Where people get coverage: FHI's tally of the U.S. Census Bureau's Current Population Survey, 2026 Annual Social and Economic Supplement, from its public-use file (asecpub26csv.zip, released September 15, 2026), for people of all ages as of their interviews from February to April 2026. Each person is counted once: anyone with Medicare under Medicare, anyone else with exactly one kind of coverage under that kind, and anyone else with two or more kinds under "more than one kind". Our tally matches the totals and margins of error Census publishes from the same survey (report P60-291, Table 1, and table H-02). Every share is within half a point either way, at 90% confidence. Medicare includes Medicare Advantage plans, which private insurers run. Job-based includes self-funded plans, where the employer pays the claims itself. Medicaid or CHIP includes other state programs for people with low incomes and Basic Health Programs, such as New York's Essential Plan. VA includes CHAMPVA, and someone with both TRICARE and VA counts under "more than one kind".
- Why this survey: it gives marketplace plans their own category and lets us count each person once. Census's American Community Survey has no marketplace category, and Census changed its coverage question for 2025, so it warns against comparing 2025 with earlier years. Census's own published shares from this survey add up to more than 100%, since people can have more than one kind. The CDC's National Health Interview Survey is a second survey, but its latest figures are for 2025 and its marketplace figures are for people under 65, so it can't show everyone in early 2026.
- Surveys and records: CMS's records count 19.2 million people with marketplace coverage in February 2026, 68.9 million on Medicare and 75.5 million on Medicaid or CHIP. Only surveys count job-based coverage and the uninsured. Census's survey finds fewer people with marketplace plans than CMS's records count. CMS counts plans in effect in February, the survey asks from February to April, and some coverage ends in between.
- Medicare and Medicaid: Medicare is CMS's Medicare Monthly Enrollment count for February 2026, from the file with data through July 2026, the 50 states and DC added up; it includes Medicare Advantage. Medicaid and CHIP is February 2026's updated count for the 50 states and DC, from CMS's State Medicaid and CHIP Applications, Eligibility Determinations, and Enrollment Data (the September 2026 release). People with both Medicare and Medicaid are in both counts. Checked October 26, 2026.
- What Denial Watch's rates cover: This page's claim denial rates are for marketplace plans in HealthCare.gov states and six states that run their own marketplace, where some figures also count plans sold outside it. Its prior authorization rates cover large Medicare Advantage plans, Medicaid plans and programs, and HealthCare.gov insurers. It has no denial rates for job-based plans or Original Medicare.
Drug costs
- Drug spending: CMS Medicare Part D Spending by Drug, 2020 to 2024. Gross spending: what Medicare, plans and patients paid together, before manufacturer rebates. CMS marks some names with an asterisk where spending per dose mixes routes of administration; no per-dose figure is shown here, so the mark is left off. The short "for" label next to each drug is its main approved use, checked against MedlinePlus or the drug's FDA label; many drugs have other uses too.
- Medicare prices: CMS's selected drugs and negotiated prices, with its 2026 fact sheet, 2027 fact sheet and 2028 fact sheet. CMS removed Xarelto from the list from January 1, 2027, because a generic is marketed, and is due to publish the 2028 prices by November 30, 2026. The price plans pay can't exceed the negotiated price plus a dispensing fee, and your share is based on it (CMS guidance). Ozempic's price also covers Rybelsus and Wegovy. Checked October 23, 2026.
- Medicare drug help: the out-of-pocket cap from CMS's 2027 rate announcement (table V-2) and Medicare.gov's pages on drug costs, Extra Help and the Prescription Payment Plan. Checked October 23, 2026.
Everything else
- Today's counter: 2025 in-network marketplace denials divided by 365 days, counted up from your local midnight. It spreads a yearly total evenly for illustration; it isn't a count of denials happening today.
- Claim files: free from employer and marketplace plans under the federal claims rules (29 CFR 2560.503-1 and 45 CFR 147.136) and from Medicaid plans (42 CFR 438.406). Medicare Advantage and drug plans may charge a reasonable amount for copying and mailing, under section 50.5.2 of CMS's appeals guidance. Checked October 19, 2026.
- Phone numbers and other sites: each taken from the office's or group's own page, checked October 23, 2026.